mrfrhealthcare

  Insulin Biosimilars Market Highlights A disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood is termed diabetes. Biosimilar insulin is designed to be highly like the original, or reference, insulin product described in a patent. As patents for major branded insulin products start to expire, several biosimilar insulin markets are expected to launch in the coming years. Insulin Biosimilars Market was valued at USD 2311 Million in 2019 and is expected to register a CAGR of14.80% during the forecast period of 2022 to 2030. The USFDA approved new insulin glargine Basilar, for type 1 and type 2 diabetes which is a biosimilar version of Sanofi’s basal insulin Lantus (insulin glargine). Additionally, Lilly and Boehringer Ingelheim’s biosimilar insulin glargine has got approval through the European Medicines Agency’s (EMA’s) Biosimilar pathway. Such o

  Global Cataract Surgery Device Market Scenario: Cataract Surgery Devices Market Size was valued at USD 8.6 billion in 2022 and is projected to grow from USD 9.1 Billion in 2023 to USD 12.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.19% during the forecast period (2022 - 2030).   The global visual impairment population is increasing gradually which is the primary driving force behind the growth of the global cataract surgery device market. Increasing prevalence of eye disorders, especially cataract which necessitates surgery and, in turn, drives the market for cataract surgery device market. The gradual rise in global geriatric population is also estimated to be a positive driving force for market growth. The aging populace is more prone to developing cataract, and the demographic shift in developed countries towards older age will lead to an increased rate of cataract surgeries. The economic upsurge in developing countries has directed the gove

  Plasma Therapy Market Highlights According to MRFR analysis, the global plasma therapy market is expected to cross USD 895.45 million by 2030 at a CAGR of 13.8%. The global plasma therapy market is driven by several factors, such as the growing prevalence of immune deficiency disorders, autoimmune disorders, bleeding disorders and rising acceptance of plasma therapy in neurology and other therapeutic indications. The surge in the adoption of therapeutic protein drugs in the cure of a broad range of clinical symptoms. This is expected to rise as a potential for the market during the forecast period. Approvals around the globe for new plasma-derived therapies will increase the demand. Thus, the above-mentioned factors are anticipated to surge the growth of the global plasma therapy market soon. Technological advancements in the field and rising awareness among the population regarding the disease and availability of the treatment are pushing the market to new heights. Plasma the

  Addison’s Disease Treatment Market Highlights The increasing prevalence of Addison’s disease and rising research & development activities to produce new products for diagnosing and treating diseases is expected to drive market growth over the forecast period. According to a report published by the National Centre for Biotechnology Information in June 2017, the incidence rate of Addison’s disease is 0.6 per 100,000 of the population per year. Despite the drivers, difficulty in diagnosis in early stages and lack of knowledge can restrain the market growth over the assessment period. The Global Addison’s Disease Market is anticipated to hold a market value of USD 587.45 million in the year 2030 and is expected to grow at a CAGR of 10.70% during the forecast period. Addison’s disease occurs when the body starts producing inadequate amounts of certain hormones produced by adrenal glands. The glands start to produce too less cortisol and aldosterone as well.  Addison’s disease is

  Medical Imaging Workstations Market Highlights The global medical imaging workstations market is projected to reach USD 6.22 Billion by 2030 at 6.9% CAGR during the forecast period 2022-2030. The medical imaging workstations has become a base technology of modern medical diagnostics for the treatment of variety of acute and chronic diseases including cardiovascular diseases and cancer. The usage of medical imaging workstations market has reduced manual workflow and increased the accuracy and precision of diagnosis tremendously in recent years. The factors influencing the growth of the market including growing government investment and funding’s for research in modernization of imaging services, favourable reimbursement policies and the on-going technological advancements in imaging systems to improve healthcare infrastructure is anticipated to boost the growth of the market over the forecast period. Additionally, increasing demand for diagnostic imaging devices and developmen

  Urinary Drainage Bags Market Highlights The urinary drainage bags market is expected to reach value of USD 234.58 million by 2030 at 7.34% CAGR during the forecast period. Urine drainage bags collect urine. Urine bags are attached to a catheter (tube) that is inside the bladder. The need for a catheter and urine drainage bag is because of urinary incontinence (leakage), urinary retention (not being able to urinate), a surgery that made a catheter necessary, or another health problem. The  urinary drainage bags market  is growing at a significant growth rate, the major factors influencing the growth of the market include growing urinary infectious diseases, increase in several urological and gynecological surgeries, increasing prevalence of urinary incontinence, increasing geriatric population. Urinary incontinence is one of the rising urology diseases in the elderly population.  Age is a major risk factor for several physical, mental, and economically devastating health disorde

  Swab Market Highlights: Swabs are the absorbent medicated pads that are used in surgery and medicine. The application of swabs ranges from cleaning the wounds to taking sample. It consists of a shaft having an absorbent mounting, which contains various active compounds such as  chlorhexidine, cetrimide, iodine etc. Such compounds have specific activity, which imparts a targeted action. However, alcohol swabs show non-specific activity. The swab market is projected to reach USD 2.6 Billion by 2030 at 6.6% CAGR during the forecast period 2022-2030. The major factor that drives the global swab market is the increasing prevalence of chronic diseases, which is followed various types of therapeutic surgeries.  According to healthcare cost and utilization project report of 2017 in the U.S., about 22 million surgeries were performed in the year 2014. Most of these surgeries were performed in a hospital-based setting, according to the WHO, by 2020 three quarters of the total deaths wi